Published in J Pain on December 01, 2002
Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol (2007) 2.00
Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol (2005) 1.30
Pulsed radiofrequency treatment of pain relieving point in a soft tissue. Korean J Pain (2011) 0.90
Palliative radiofrequency ablation for recurrent prostate cancer. Cardiovasc Intervent Radiol (2006) 0.88
Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol (1996) 3.93
Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am (1998) 3.56
Image-guided radiofrequency tumor ablation: challenges and opportunities--part II. J Vasc Interv Radiol (2001) 2.66
Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms. J Vasc Interv Radiol (2001) 1.70
New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med (1994) 1.70
Percutaneous tumor ablation with radiofrequency. Cancer (2002) 1.31
Radiofrequency ablation for chronic pain control. Curr Pain Headache Rep (2001) 0.89
Experience with radiofrequency ablation in the treatment of pelvic recurrence in rectal cancer: report of two cases. Dis Colon Rectum (2001) 0.88
Opioid and Nonopioid Therapy in Cancer Pain: The Traditional and the New. Curr Rev Pain (1999) 0.84
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol (2013) 4.64
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol (2013) 2.81
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol (2013) 2.62
Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol (2012) 2.55
Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology (2003) 2.53
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg (2008) 2.39
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology (2010) 2.38
Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology (2013) 2.35
Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol (2009) 2.29
Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. Clin Cancer Res (2007) 2.17
D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol (2011) 2.10
Effects of perfusion on radiofrequency ablation in swine kidneys. Radiology (2004) 2.07
Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol (2007) 2.00
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer (2013) 1.97
Closed-loop control in fused MR-TRUS image-guided prostate biopsy. Med Image Comput Comput Assist Interv (2007) 1.95
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology (2009) 1.95
Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics (2004) 1.92
Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience. Diabetes Care (2003) 1.86
Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int (2007) 1.86
Pulsed high-intensity focused ultrasound enhances apoptosis and growth inhibition of squamous cell carcinoma xenografts with proteasome inhibitor bortezomib. Radiology (2008) 1.82
Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. Radiology (2014) 1.78
Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol (2002) 1.74
Pulsed high-intensity focused ultrasound enhances thrombolysis in an in vitro model. Radiology (2006) 1.51
Percutaneous ablation in the kidney. Radiology (2011) 1.51
Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model. J Control Release (2011) 1.49
Metastatic involvement of a retrieved inferior vena cava filter. J Vasc Interv Radiol (2003) 1.49
CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis. Chest (2002) 1.45
Percutaneous radiofrequency ablation of chordoma. AJR Am J Roentgenol (2002) 1.45
Clinical utility of real-time fusion guidance for biopsy and ablation. J Vasc Interv Radiol (2011) 1.44
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int (2012) 1.42
Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol (2004) 1.42
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer. Cancer (2007) 1.36
Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med (2012) 1.34
Precision targeting of liver lesions using a novel electromagnetic navigation device in physiologic phantom and swine. Med Phys (2005) 1.30
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology (2012) 1.28
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology. J Magn Reson Imaging (2013) 1.27
Documenting the location of prostate biopsies with image fusion. BJU Int (2011) 1.23
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int (2014) 1.22
Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol (2009) 1.21
Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study. Thromb Res (2007) 1.21
Radiofrequency ablation beyond the liver. Tech Vasc Interv Radiol (2002) 1.19
Multimodality image fusion-guided procedures: technique, accuracy, and applications. Cardiovasc Intervent Radiol (2012) 1.18
A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer. Oncology (2011) 1.18
Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int (2014) 1.18
Mild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug delivery. Int J Hyperthermia (2012) 1.17
Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound. Int J Hyperthermia (2011) 1.17
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2. Clin Cancer Res (2010) 1.16
Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation. Int J Hyperthermia (2010) 1.14
Combination therapy with local radiofrequency ablation and systemic vaccine enhances antitumor immunity and mediates local and distal tumor regression. PLoS One (2013) 1.14
Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. Radiology (2011) 1.13
Palliation of soft tissue cancer pain with radiofrequency ablation. J Support Oncol (2004) 1.08
Malignant insulinoma: spectrum of unusual clinical features. Cancer (2005) 1.07
Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol (2005) 1.06
Remote thermometry to avoid complications in radiofrequency ablation. J Vasc Interv Radiol (2003) 1.05
Operative management for recurrent and metastatic adrenocortical carcinoma. J Surg Oncol (2011) 1.05
Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J Control Release (2010) 1.04
Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology. J Vasc Interv Radiol (2012) 1.02
Interventional optical molecular imaging guidance during percutaneous biopsy. Radiology (2014) 1.02
Phase I study of heat-deployed liposomal doxorubicin during radiofrequency ablation for hepatic malignancies. J Vasc Interv Radiol (2011) 1.02
Simultaneous integrated boost of biopsy proven, MRI defined dominant intra-prostatic lesions to 95 Gray with IMRT: early results of a phase I NCI study. Radiat Oncol (2007) 1.01
Image-guided adrenal and renal biopsy. Tech Vasc Interv Radiol (2010) 1.00
Comparison of three different needles for percutaneous injections. Cardiovasc Intervent Radiol (2006) 1.00
Thermal protection with 5% dextrose solution blanket during radiofrequency ablation. Cardiovasc Intervent Radiol (2006) 0.99
Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis. Clin Imaging (2003) 0.99
Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation. Int J Hyperthermia (2012) 0.99
In vitro and in vivo evaluations of increased effective beam width for heat deposition using a split focus high intensity ultrasound (HIFU) transducer. Int J Hyperthermia (2008) 0.99
Radiofrequency cauterization with biopsy introducer needle. J Vasc Interv Radiol (2004) 0.98
Use of hydrodissection to prevent nerve and muscular damage during radiofrequency ablation of kidney tumors. J Vasc Interv Radiol (2006) 0.98
Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model. PLoS One (2012) 0.96
Cone-beam computed tomography fusion and navigation for real-time positron emission tomography-guided biopsies and ablations: a feasibility study. J Vasc Interv Radiol (2012) 0.96
Hepatic radiofrequency ablation at low frequencies preferentially heats tumour tissue. Int J Hyperthermia (2006) 0.95
Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine. J Vasc Interv Radiol (2011) 0.95
Radiofrequency ablation for tumor-related massive hematuria. J Vasc Interv Radiol (2005) 0.93
Accuracy and efficacy of percutaneous biopsy and ablation using robotic assistance under computed tomography guidance: a phantom study. Eur Radiol (2013) 0.92
Liver resection and ablation for metastatic adrenocortical carcinoma. Ann Surg Oncol (2011) 0.92
Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches. BJU Int (2014) 0.92
Radiofrequency ablation of renal tumors. Tech Vasc Interv Radiol (2007) 0.91
Development of "imageable" beads for transcatheter embolotherapy. J Vasc Interv Radiol (2010) 0.91
Recent advances in image-guided targeted prostate biopsy. Abdom Imaging (2015) 0.91
Multiparametric magnetic resonance imaging and image-guided biopsy to detect seminal vesicle invasion by prostate cancer. J Endourol (2014) 0.89
Accelerated T2 mapping for characterization of prostate cancer. Magn Reson Med (2011) 0.89
MRI of localized prostate cancer: coming of age in the PSA era. Diagn Interv Radiol (2011) 0.89
Reduction of peak acoustic pressure and shaping of heated region by use of multifoci sonications in MR-guided high-intensity focused ultrasound mediated mild hyperthermia. Med Phys (2013) 0.89
Dual-phase cone-beam computed tomography to see, reach, and treat hepatocellular carcinoma during drug-eluting beads transarterial chemo-embolization. J Vis Exp (2013) 0.89
CT fluoroscopy shielding: decreases in scattered radiation for the patient and operator. J Vasc Interv Radiol (2006) 0.89
Electromagnetic tracking for abdominal interventions in computer aided surgery. Comput Aided Surg (2006) 0.88
Palliative radiofrequency ablation for recurrent prostate cancer. Cardiovasc Intervent Radiol (2006) 0.88
US-guided fine-needle aspiration biopsy of thyroid nodules: adequacy of cytologic material and procedure time with and without immediate cytologic analysis. Radiology (2002) 0.87
Electromagnetic navigation for thoracic aortic stent-graft deployment: a pilot study in swine. J Vasc Interv Radiol (2010) 0.87
Heavy metal pad shielding during fluoroscopic interventions. J Vasc Interv Radiol (2006) 0.86
Contribution of direct heating, thermal conduction and perfusion during radiofrequency and microwave ablation. Open Biomed Eng J (2007) 0.86